Tuesday, July 15, 2025 | 07:58 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Pharma Stocks

Sun Pharma shares rise 2% on US launch of hair loss drug after settlement

Sun Pharma shares rose nearly 2 per cent on Tuesday after the company launched Leqselvi, a new treatment for severe alopecia areata

Sun Pharma shares rise 2% on US launch of hair loss drug after settlement
Updated On : 15 Jul 2025 | 11:55 AM IST

Wockhardt shares rise 2% after exiting US generics business

Wockhardt shares rose 2 per cent after it decided to exit the US generic pharmaceutical segment after incurring consistent losses

Wockhardt shares rise 2% after exiting US generics business
Updated On : 14 Jul 2025 | 10:53 AM IST

Gland Pharma shares rise on GMP nod for Telangana manufacturing unit

Gland Pharma shares rose 2 per cent after it received a GMP certification from the Danish Medicines Agency for its Telangana plant

Gland Pharma shares rise on GMP nod for Telangana manufacturing unit
Updated On : 14 Jul 2025 | 10:29 AM IST

Glenmark Pharma soars 10%, hits 52-week high on cancer drug licensing deal

At 09:30 AM, Glenmark Pharma shares were trading at ₹2,094.40, up by 10 per cent on the National Stock Exchange.

Glenmark Pharma soars 10%, hits 52-week high on cancer drug licensing deal
Updated On : 11 Jul 2025 | 10:23 AM IST

Here's why Shilpa Medicare share price is buzzing in trade today; details

Shilpa Medicare shares rose today after the company secured GMP certification from Saudi Arabia's SFDA for its Unit VI facility in Dabaspet, Bengaluru.

Here's why Shilpa Medicare share price is buzzing in trade today; details
Updated On : 10 Jul 2025 | 1:09 PM IST

Glenmark hits new high; zooms 37% in 2 months; what's driving pharma stock?

Since June 25, in 12 trading days, the stock has surged 12% after the company launched the lung cancer treatment drug Tevimbra in India, following the approval by the CDSCO.

Glenmark hits new high; zooms 37% in 2 months; what's driving pharma stock?
Updated On : 10 Jul 2025 | 12:21 PM IST

Emcure Pharma rises over 2% as USFDA issues Form 483 with Zero observations

Emcure Pharma share price rose in trade after the company announced that United States Food and Drug Administration (USFDA) issued Form 483 with zero observations for its Sanand, Ahmedabad unit.

Emcure Pharma rises over 2% as USFDA issues Form 483 with Zero observations
Updated On : 10 Jul 2025 | 11:41 AM IST

Lupin share pops 2% on licencing and supply agreement with Zentiva; details

Lupin's share price rose in trade today after the company announced a licensing and supply agreement with Zentiva, k.s., for the commercialisation of its biosimilar Certolizumab Pegol.

Lupin share pops 2% on licencing and supply agreement with Zentiva; details
Updated On : 09 Jul 2025 | 11:18 AM IST

Glenmark, Laurus Lab: Will Trump's 200% tariff threat derail pharma stocks?

Donald Trump threatens of a potential 200% tariff on pharma imports; can this derail the rally in pharma shares, which have gained up to 50% in 3 months. Here's what the technical charts suggest.

Glenmark, Laurus Lab: Will Trump's 200% tariff threat derail pharma stocks?
Updated On : 09 Jul 2025 | 10:34 AM IST

Alembic Pharmaceuticals up 2% as arm acquires Utility Therapeutics; details

Alembic Pharmaceuticals share price rose after the company announced that its wholly-owned subsidiary, Alembic Pharmaceuticals Inc., has acquired Utility Therapeutics Ltd. for approximately $12 mn

Alembic Pharmaceuticals up 2% as arm acquires Utility Therapeutics; details
Updated On : 03 Jul 2025 | 11:16 AM IST

AstraZeneca Pharma pops 4% on CDSCO nod to import Durvalumab solution

AstraZeneca Pharma shares rose after the company received regulatory approval to expand the use of its cancer drug Imfinzi (Durvalumab) in India.

AstraZeneca Pharma pops 4% on CDSCO nod to import Durvalumab solution
Updated On : 02 Jul 2025 | 12:38 PM IST

Laurus up for 9th straight day, soars 23% in 1 month. What's driving stock?

Scale-up of the CDMO segment in FY26, is expected to contribute meaningfully to revenue growth and margin expansion, aided by better capacity utilisation and operational execution, CareEdge Ratings.

Laurus up for 9th straight day, soars 23% in 1 month. What's driving stock?
Updated On : 02 Jul 2025 | 11:45 AM IST

Why is Alembic Pharmaceuticals' share in demand today? Key details here

Alembic Pharmaceuticals share surged after the company received final approval from the USFDA for its ANDA for Doxorubicin Hydrochloride Liposome Injection in two dosage strength.

Why is Alembic Pharmaceuticals' share in demand today? Key details here
Updated On : 30 Jun 2025 | 12:22 PM IST

JP Morgan upgrades Torrent Pharma to 'Overweight', lifts target; stk up 5%

Torrent Pharma share price rose after JPMorgan reportedly upgraded the company to 'Overweight'. The brokerage also hiked the target price to ₹3,800, from ₹3,650 earlier.

JP Morgan upgrades Torrent Pharma to 'Overweight', lifts target; stk up 5%
Updated On : 27 Jun 2025 | 2:09 PM IST

Glenmark Pharmaceuticals shares up 3% on launching cancer drug Tevimbra

Glenmark Pharmaceuticals share price gained in trade after the company announced the launch of Tevimbra (tislelizumab) in India, following approval by the Central Drugs Standard Control Organisation.

Glenmark Pharmaceuticals shares up 3% on launching cancer drug Tevimbra
Updated On : 25 Jun 2025 | 1:11 PM IST

Why did Natco Pharma's share price slip 3% in trade today? Details here

Natco Pharma shares slipped in trade after the company said that the USFDA has issued one (1) observation in the Form-483 for its API manufacturing plant in Mekaguda, Hyderabad.

Why did Natco Pharma's share price slip 3% in trade today? Details here
Updated On : 16 Jun 2025 | 10:40 AM IST

Sun Pharma share slips 2% as USFDA flags 8 observations for Halol facility

Sun Pharma shares dropped in trade after the company announced that United States Food and Drug Administration (USFDA) has issued a Form-483, with 8 observations for its Halol facility in Gujarat.

Sun Pharma share slips 2% as USFDA flags 8 observations for Halol facility
Updated On : 16 Jun 2025 | 10:17 AM IST

Why is Jubilant Pharmova share price buzzing in an overall weak market?

Jubilant Pharmova shares rose after its board approved the slump sale of its API business to wholly-owned subsidiary, Jubilant Biosys.

Why is Jubilant Pharmova share price buzzing in an overall weak market?
Updated On : 13 Jun 2025 | 10:24 AM IST

Eris soars 11% on Thursday, zooms 61% from low; is it time to book profit?

The stock of the pharmaceutical company Eris Lifesciences was trading higher for the third straight day, soaring 17 per cent during the period.

Eris soars 11% on Thursday, zooms 61% from low; is it time to book profit?
Updated On : 12 Jun 2025 | 3:01 PM IST

Breakout stocks: Nifty Pharma, Biocon, Cipla break over 200-DMA; what next?

The Nifty Pharma index and select shares such as Biocon, Cipla, Zydus Life and Gland Pharma were trading above the respective 200-DMAs after more than 2 months; show technical charts.

Breakout stocks: Nifty Pharma, Biocon, Cipla break over 200-DMA; what next?
Updated On : 12 Jun 2025 | 1:05 PM IST